CIM Investment Management’s GSK GSK Stock Holding History

CIM Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-5,054	Closed	-$338K	–	191
2014 Q1	$338K	Buy	+5,054	New	+$342K	0.16%	150

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CIM Investment Management's GSK Position: Q2 2014 in Review

CIM Investment Management sold out of GSK (GSK) in Q2 2014, closing a stake of 5,054 shares — an estimated $338K sold.

CIM Investment Management first reported a position in GSK in Q1 2014 and held it in 1 quarter. The position peaked at $338K in Q1 2014. 722 funds tracked by Wall St. Rank hold GSK as of Q2 2014.

CIM Investment Management reported no remaining GSK position as of Q2 2014 after selling out during the quarter.
CIM Investment Management sold 5,054 GSK shares in Q2 2014, an estimated $338K.
CIM Investment Management first reported a position in GSK in Q1 2014 and held it in 1 quarter.
CIM Investment Management's GSK position peaked at $338K in Q1 2014.
722 funds tracked by Wall St. Rank held GSK as of Q2 2014.

Based on CIM Investment Management's 13F filing for Q2 2014, filed 14 Aug 2014.